Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
1-Minute Consult

Should I refer my patient for a parathyroidectomy?

Gustavo Romero-Velez, MD, Leila Zeinab Khan, MD and Judy Jin, MD
Cleveland Clinic Journal of Medicine May 2024, 91 (5) 279-280; DOI: https://doi.org/10.3949/ccjm.91a.23076
Gustavo Romero-Velez
Department of Endocrine Surgery, Cleveland Clinic, Cleveland, OH; Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leila Zeinab Khan
Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic, Cleveland, OH; Medical Director of the Calcium Center, Cleveland Clinic, Cleveland, OH; Clinical Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Find this author on Cleveland Clinic
Judy Jin
Department of Endocrine Surgery, Cleveland Clinic, Cleveland, OH; Surgical Director of the Calcium Center, Cleveland Clinic, Cleveland, OH; Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Find this author on Cleveland Clinic
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

A 60-year-old woman who is otherwise healthy is found to have an elevated serum calcium level of 10.5 mg/dL (reference range 8.5–10.2) during her yearly checkup. Her main complaints are memory loss and fatigue, but she denies prior fractures or kidney stones. Review of her medical record shows that her calcium levels have been persistently elevated for at least the past 5 years. Additional workup demonstrates a parathyroid hormone level (PTH) of 55 pg/mL (15–65), 25-hydroxyvitamin D level of 40 ng/mL (31–80), and 24-hour urine calcium excretion of 240 mg (100–300). She has known osteopenia, with a T-score of −2.4 at the femoral neck. Her serum creatinine level is normal. Should this patient be referred for parathyroidectomy?

In patients with primary hyperparathyroidism, the decision to refer for surgery should be individualized and not based solely on whether the patient meets guideline criteria. The first question that must be addressed then is whether our patient has primary hyperparathyroidism.

She has hypercalcemia (serum level of 10.5 mg/dL) with a replete 25-vitamin D level, and although her PTH level at greater than 30 pg/mL is within the normal range, it is still inappropriately high, confirming the diagnosis of primary hyperparathyroidism. Traditionally, the diagnosis of primary hyperparathyroidism was made based on concomitant calcium and PTH levels above the normal limits, but we now recognize that what matters is the relationship of the levels rather than the absolute values.1

Also, although the diagnosis is clear in this patient with hypercalcemia and an inappropriately high PTH, familial hypocalciuric hypercalcemia should be considered in the differential. Familial hypocalciuric hypercalcemia, though far less common than primary hyperparathyroidism, presents with similar biochemical patterns, except for hypocalciuria (< 100 mg/24 hours). The urine calcium:creatinine clearance ratio may help distinguish between the 2 conditions.2

The next question—should our patient be referred for parathyroidectomy?—is more complex. According to current international consensus guidelines, she does not meet the criteria for surgery because her serum calcium is not 1.0 mg/dL above the upper limit of normal, she is older than 50, and she does not have osteoporosis, nephrolithiasis, fractures, decreased creatinine clearance, or hypercalciuria (Table 1).2 The decision to treat, however, should not rely solely on whether the patient meets guideline criteria. Surgery can improve bone health, reduce the likelihood of nephrolithiasis or even chronic kidney disease, and improve serum calcium values. Also, several neuropsychiatric symptoms are likely to improve with surgery, such as fatigue and brain fog.1

View this table:
  • View inline
  • View popup
TABLE 1

International criteria for parathyroid surgery in patients with primary hyperparathyroidism

INDIVIDUALIZING THE DECISION TO TREAT

Research indicates that the level of hypercalcemia does not correlate with the presence of symptoms.3 Thus, our patient may still be prone to symptoms attributable to primary hyperparathyroidism with her calcium level of 10.5 mg/dL. Her age also may not be relevant and should be seen as being part of a continuum rather than a specific cutoff point. Given current life-expectancy estimates, patients older than age 50 can still be at risk for additional long-term manifestations of the disease. In fact, parathyroidectomy is the most cost-effective strategy for patients with at least 3 years of life expectancy based on fracture risk reduction.4

Related to bone health, while our patient does not meet the bone mineral density criterion (T-score ≤ −2.5) for surgery, the T-score also should be seen as a continuum. She likely will progress and eventually meet the criterion, as untreated primary hyperparathyroidism can cause significant bone loss.5 Parathyroidectomy can improve bone mineral density and reduce the risk of fractures.5,6

Finally, our patient presented with neurocognitive symptoms that included memory loss and fatigue. Though still a matter of debate, there is growing evidence that these symptoms and quality of life can improve after parathyroidectomy.1,7,8

Careful evaluation of this patient indicates she would benefit from consultation with a high-volume parathyroid surgeon.

THE BOTTOM LINE

Primary hyperparathyroidism is frequently underrecognized and underdiagnosed. It is the most common cause of hypercalcemia in the outpatient setting.9 While consensus guidelines may be useful in large population studies, individualizing care is most important. Surgical correction can result in improvements in health and quality of life. It is essential to recognize hypercalcemia with nonsuppressed PTH values and to individualize treatment for each patient even when the exact surgical criteria are not met. In patients presenting at a young age or with strong family history, hereditary endocrinopathies must be considered.

DISCLOSURES

The authors report no relevant financial relationships which, in the context of their contributions, could be perceived as a potential conflict of interest.

  • Copyright © 2024 The Cleveland Clinic Foundation. All Rights Reserved.

REFERENCES

  1. ↵
    1. Wilhelm SM,
    2. Wang TS,
    3. Ruan DT, et al
    . The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg 2016; 151(10):959–968. doi:10.1001/jamasurg.2016.2310
    OpenUrlCrossRefPubMed
  2. ↵
    1. Bilezikian JP,
    2. Khan AA,
    3. Silverberg SJ, et al
    . Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop. J Bone Miner Res 2022; 37(11):2293–2314. doi:10.1002/jbmr.4677
    OpenUrlCrossRef
  3. ↵
    1. Boone D,
    2. Politz D,
    3. Lopez J,
    4. Mitchell J,
    5. Parrack K,
    6. Norman J
    . Concentration of serum calcium is not correlated with symptoms or severity of primary hyperparathyroidism: an examination of 20,081 consecutive adults. Surgery 2017; 161(1):98–106. doi:10.1016/j.surg.2016.09.012
    OpenUrlCrossRef
  4. ↵
    1. Zanocco KA,
    2. Wu JX,
    3. Yeh MW
    . Parathyroidectomy for asymptomatic primary hyperparathyroidism: a revised cost-effectiveness analysis incorporating fracture risk reduction. Surgery 2017; 161(1):16–24. doi:10.1016/j.surg.2016.06.062
    OpenUrlCrossRef
  5. ↵
    1. Seib CD,
    2. Meng T,
    3. Suh I, et al
    . Risk of fracture among older adults with primary hyperparathyroidism receiving parathyroidectomy vs nonoperative management. JAMA Intern Med 2022; 182(1):10–18. doi:10.1001/jamainternmed.2021.6437
    OpenUrlCrossRefPubMed
  6. ↵
    1. Lundstam K,
    2. Pretorius M,
    3. Bollerslev J, et al
    . Positive effect of parathyroidectomy compared to observation on BMD in a randomized controlled trial of mild primary hyperparathyroidism. J Bone Miner Res 2023; 38(3):372–380. doi:10.1002/jbmr.4763
    OpenUrlCrossRef
  7. ↵
    1. Pretorius M,
    2. Lundstam K,
    3. Hellström M, et al
    . Effects of parathyroidectomy on quality of life: 10 years of data from a prospective randomized controlled trial on primary hyperparathyroidism (the SIPH-Study). J Bone Miner Res 2021; 36(1):3–11. doi:10.1002/jbmr.4199
    OpenUrlCrossRef
  8. ↵
    1. Ambrogini E,
    2. Cetani F,
    3. Cianferotti L, et al
    . Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab 2007; 92(8):3114–3121. doi:10.1210/jc.2007-0219
    OpenUrlCrossRefPubMed
  9. ↵
    1. Press DM,
    2. Siperstein AE,
    3. Berber E, et al
    . The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record. Surgery 2013; 154(6):1232–1238. doi:10.1016/j.surg.2013.06.051
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 91 (5)
Cleveland Clinic Journal of Medicine
Vol. 91, Issue 5
1 May 2024
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Should I refer my patient for a parathyroidectomy?
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Should I refer my patient for a parathyroidectomy?
Gustavo Romero-Velez, Leila Zeinab Khan, Judy Jin
Cleveland Clinic Journal of Medicine May 2024, 91 (5) 279-280; DOI: 10.3949/ccjm.91a.23076

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Should I refer my patient for a parathyroidectomy?
Gustavo Romero-Velez, Leila Zeinab Khan, Judy Jin
Cleveland Clinic Journal of Medicine May 2024, 91 (5) 279-280; DOI: 10.3949/ccjm.91a.23076
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • INDIVIDUALIZING THE DECISION TO TREAT
    • THE BOTTOM LINE
    • DISCLOSURES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • What diagnostic tests should be done after discovering clubbing in a patient without cardiopulmonary symptoms?
  • Does my adult patient need a measles vaccine?
  • Do I need to treat supine hypertension in my hospitalized patient?
Show more 1-Minute Consult

Similar Articles

Subjects

  • Endocrinology

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire